23 April 2019 - The Beneluxa collaboration is an initiative aimed at securing sustainable access to new medicines.
It was established in April 2015 by Belgium and the Netherlands. Luxembourg and Austria have joined since. Ireland became a member in June 2018. Beneluxa’s stated goal is to ensure “timely access and affordability of medicines” .
It aims to achieve this through five principal activities: joint horizon scanning; mutual recognition of heath technology assessments (HTAs); sharing policy expertise and best practice; enhanced bargaining power through joint price negotiation; and, improved price transparency.